Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Symptomatic delayed seromas vs incidental findings on MR, and likelihood of BIA-ALCL in women with textured implants
    Meeting Abstract

    Ghione, P.; Sutton, E. J.; Hu, Q.; Galasso, N.; Ganesan, N.; Tyagi, N.; Martinez, D. F.; Dogan, A.; Morris, E. A.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Changes in Ki-67 and cleaved caspase-3 (CC3) with short term androgen deprivation therapy (ADT) prior to prostatectomy as part of a trial in intermediate and high-risk prostate cancer (PC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Chen, Y. B.; Autio, K. A.; Carver, B. S.; Slovin, S. F.; Danila, D. C.; Scher, H. I.; Touijer, K. A.; Rathkopf, D. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of chemotherapy-induced peripheral neuropathy (CIPN) using patient-reported outcomes (PRO) and quantitative sensory testing (QST)
    Meeting Abstract

    Bao, T.; Zhi, W. I.; Chen, C.; Baser, R. E.; Li, Q. S.; Panageas, K.; Harte, S.; Mao, J. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model
    Meeting Abstract

    Alvim, R.; Nogueira, L.; Georgala, P. M.; Somma, A.; Nagar, K.; Thomas, J.; Ledbai, S.; Hudges, C.; Scherz, A. J.; Zanganeh, S. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
    Meeting Abstract

    Yuan, X.; Zhang, X.; Du, R.; Cheung, S. H.; Wei, M.; Zhou, C.; Wang, L.; Shearer, T.; Edris, B.; Smith, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity
    Meeting Abstract

    Zhang, Z.; Zhou, C.; Li, X.; Barnes, S.; Deng, S.; Hoover, E.; Chen, C. C.; Lee, Y. S.; Wang, C.; Tirado, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • UGP2 is a critical regulator of protein glycosylation in pancreatic cancer
    Meeting Abstract

    Wolfe, A. L.; Galeas, J.; Toska, E.; Zhou, Q.; Ku, A.; Koche, R. P.; Bandyopadhyay, S.; Lebrilla, C. B.; Scaltriti, M.; McCormick, F.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Rapid non-uniform adaptation to conformation-specific KRAS G12Cinhibition
    Meeting Abstract

    Xue, J. Y.; Zhao, Y.; Aronowitz, J.; Mai, T. T.; Vides, A.; Qeriqi, B.; Kim, D.; Li, C.; de Stanchina, E.; Mazutis, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The protein phosphatase 4 complex is a tumor suppressor in prostate cancer
    Meeting Abstract

    Watson, P. A.; Lawrence, K. E.; Nadkarni, T. V.; Ishmael, T. F.; Lee, E.; Agudelo Rivera, A. C.; Love, J. R.; Wongvipat, J.; Cai, L.; Nazir, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save